94
Views
16
CrossRef citations to date
0
Altmetric
REVIEWS

Developments in Epidermal Growth Factor Receptor-Targeting Therapy for Solid Tumors: Focus on Matuzumab (EMD 72000)

Pages 81-95 | Published online: 11 Jun 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Stephen J. Demarest, Kandasamy Hariharan & Jianying Dong. (2011) Emerging antibody combinations in oncology. mAbs 3:4, pages 338-351.
Read now
Sonia Garofalo, Roberta Rosa, Roberto Bianco & Giampaolo Tortora. (2008) EGFR-targeting agents in oncology. Expert Opinion on Therapeutic Patents 18:8, pages 889-901.
Read now

Articles from other publishers (14)

Deyong He, Rongyuan Yuan & Lijun Liu. (2023) Rational Identification of Conformational and Linear EGFR Epitopes Recognized Specifically by, Respectively, Type-I and Type-II Anti-EGFR Antibodies and Molecular Design of Linear Epitope-Derived Peptidic Mimotopes to Elicit Type-II Antibody. International Journal of Peptide Research and Therapeutics 29:3.
Crossref
Max Sauter, Matthias Strieker, Christian Kleist, Artjom Wischnjow, Volker Daniel, Annette Altmann, Uwe Haberkorn & Walter Mier. (2020) Improving antibody-based therapies by chemical engineering of antibodies with multimeric cell-penetrating peptides for elevated intracellular delivery. Journal of Controlled Release 322, pages 200-208.
Crossref
Shima Moradi-Kalbolandi, Aysooda Hosseinzade, Malihe Salehi, Parnaz Merikhian & Leila Farahmand. (2018) Monoclonal antibody-based therapeutics, targeting the epidermal growth factor receptor family: from herceptin to Pan HER. Journal of Pharmacy and Pharmacology 70:7, pages 841-854.
Crossref
Jin Sheng, Yun-Peng Yang, Yuan-Yuan Zhao, Tao Qin, Zhi-Huang Hu, Ting Zhou, Ya-Xiong Zhang, Shao-Dong Hong, Yu-Xiang Ma, Hong-Yun Zhao, Yan Huang & Li Zhang. (2015) The Efficacy of Combining EGFR Monoclonal Antibody With Chemotherapy for Patients With Advanced Nonsmall Cell Lung Cancer. Medicine 94:34, pages e1400.
Crossref
Elisa Nigro, Antonio Siccardi & Luca Vangelista. (2013) Role and Redirection of IgE against Cancer. Antibodies 2:4, pages 371-391.
Crossref
Edzard Spillner, Melanie Plum, Simon Blank, Michaela Miehe, Josef Singer & Ingke Braren. (2012) Recombinant IgE antibody engineering to target EGFR. Cancer Immunology, Immunotherapy 61:9, pages 1565-1573.
Crossref
Keith D. Hunter & Robert Bolt. 2012. Biotargets of Cancer in Current Clinical Practice. Biotargets of Cancer in Current Clinical Practice 19 59 .
John Cannon. 2011. Drug Delivery Systems, Third Edition. Drug Delivery Systems, Third Edition 47 78 .
Roberto Bianco, Teresa Gelardi, Sonia Garofalo, Roberta Rosa & Giampaolo Tortora. 2010. Macromolecular Anticancer Therapeutics. Macromolecular Anticancer Therapeutics 407 436 .
Thomas Seufferlein, Johann Ahn, Denis Krndija, Ulrike Lother, Guido Adler & Götz von Wichert. (2009) Tumor biology and cancer therapy – an evolving relationship. Cell Communication and Signaling 7:1.
Crossref
Thomas K. Hoffmann, Kerstin Schirlau, Enikö Sonkoly, Sven Brandau, Stephan Lang, Andor Pivarcsi, Vera Balz, Anja Müller, Bernhard Homey, Edwin Boelke, Torsten Reichert, Ulrike Friebe‐Hoffmann, Jens Greve, Patrick Schuler, Kathrin Scheckenbach, Jörg Schipper, Murat Bas, Theresa L. Whiteside & Henning Bier. (2009) A novel mechanism for anti‐EGFR antibody action involves chemokine‐mediated leukocyte infiltration. International Journal of Cancer 124:11, pages 2589-2596.
Crossref
Karl R. Schmitz & Kathryn M. Ferguson. (2009) Interaction of antibodies with ErbB receptor extracellular regions. Experimental Cell Research 315:4, pages 659-670.
Crossref
Dina K. Patel. (2012) Clinical Use of Anti‐Epidermal Growth Factor Receptor Monoclonal Antibodies in Metastatic Colorectal Cancer. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 28:11P2.
Crossref
Srinivasan Krishnamoorthy. (2008) Receptor Tyrosine Kinase (RTK) Mediated Tyrosine Phosphor-Proteome from Drosophila S2 (ErbB1) Cells Reveals Novel Signaling Networks. PLoS ONE 3:8, pages e2877.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.